TEDDY Network is one of the 50th associations from 18 countries signed a Manifesto with 10 Recommendations addressed to European institutions, to remark the unmet needs of non-Covid patients, launched by Active Citizenship Network (ACN) on the occasion of the recent...
The article "Children’s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure)" has been published in Pharmaceutics as part of the Special Issue Scientific Highlights in the...
The article ‘Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults’, published on JAMA Pediatrics, is the result of a systematic review and meta-analysis including 32 studies, children and adolescents younger than 20 years had 44%...
The Clinical Trials Regulation (EU) 536/2014 is foreseen to become applicable at the end of January 2022. To support Member States with its implementation, DG SANTE of the European Commission, the European Medicines Agency (EMA) and the Clinical Trials Facilitation...
As part of the EU pharmaceuticals strategy, and drawing lessons from the COVID-19 pandemic, the Commission launched an inception impact assessment to evaluate and revise the EU’s general legislation on medicines for human use to ensure a future-proof and...
EPMD is a database containing information (indication, dosages, age of use, clinical studies, etc.) on paediatric drugs authorised by the European Medicines Agency (EMA) under the centralised procedure. Through this tool TEDDY Network supports the transparency of the...
On April 9th 2021, TEDDY network provided its feedback to the European Commission public consultation on the revision of the Europe’s strategy for international cooperation in research and innovation. The current strategy for international cooperation on research and...
The European Joint Programme on Rare Diseases has launched its first academic education course “Diagnosing Rare Diseases: from the Clinic to Research and back” related to diagnosis in the rare disease’s context. The course, started on April 26th, will last 5 weeks...
We are happy to inform you that the article "Diagnosis and Treatment of Chronic Neuropathic and Mixed Pain in Children and Adolescents: Results of a Survey Study amongst Practitioners" has been published in Children open access journal. The article shows the results...
The VISION-DMD published a white paper on how to return individual clinical trial results back to patients. It focuses on addressing the ethical and technical challenges, using the vamorolone clinical trial experience. The VISION-DMD is a project aimed to advance and...